EQUITY | NOTE 7. EQUITY Initial Public Offering (“IPO”) On July 1 ,2021, the Company completed an IPO of common stock on the Nasdaq under the symbol “VRAR”, at a price of $ 7.00 The Company sold approximately 1.91 11.82 In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase 87,500 7.00 The warrant is valued at approximately $520,000 based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 129% expected volatility, 0.87% risk-free rate and 0% expected dividend yield. As stated in Note 6, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through the issuance of 324,150 280,000 THE GLIMPSE GROUP, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) SEPTEMBER 30, 2021 AND 2020 Common Stock Issued Common stock sold to Investors During the three months ended September 30, 2021, the Company sold approximately 1.91 7.00 11.82 During the three months ended September 30, 2020, the Company sold approximately 2,400 4.50 10,800 Common stock issued to Investors During the three months ended September 30, 2021, in connection with the conversion of convertible promissory notes and in conjunction with the IPO, the Company issued 324,150 Common stock issued for Acquisition During the three months ended September 30, 2021 the Company issued approximately 77,000 0.75 Common stock issued for Legacy Acquisition Obligation During the three months ended September 30, 2021 the Company issued 375,000 shares of common stock to satisfy a legacy acquisition obligation of $ 750,000 (see Note 5). This was accomplished by settling outstanding stock options the acquiree had been granted at $ 2.00 per share. Common stock issued to Vendors During the three months ended September 30, 2021 and 2020, the Company issued approximately 6,000 6,700 65,000 30,000 3,000 15,000 Common stock issued for Exercise of options During the three months ended September 30, 2021, the Company issued approximately 17,000 46,000 Employee Stock-Based Compensation The Company’s 2016 Equity Incentive Plan (the “Plan”), as amended, has 10 5.64 The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period. THE GLIMPSE GROUP, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) SEPTEMBER 30, 2021 AND 2020 Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table: SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS Three Months Ended Three Months Ended Weighted average expected terms (in years) 5.4 5.1 Weighted average expected volatility 146.1 % 117.3 % Weighted average risk-free interest rate 0.9 % 0.3 % Expected dividend yield 0.0 % 0.0 % The grant date fair value, for options granted during the three months ended September 30, 2021 and 2020 was approximately $ 0.61 0.40 The following is a summary of the Company’s stock option activity for the three months ended September 30, 2021 and 2020: SUMMARY OF STOCK OPTION ACTIVITY Weighted Average Remaining Exercise Contractual Intrinsic Options Price Term (Yrs) Value Outstanding at July 1, 2021 4,740,910 $ 3.40 8.5 $ 7,893,467 Options Granted 94,666 7.11 9.9 423,923 Options Exercised (392,394 ) 2.14 7.2 (3,720,795 ) Options Forfeited / Cancelled (82,838 ) 4.61 9.5 (563,393 ) Outstanding at September 30, 2021 4,360,344 $ 3.58 8.6 $ 16,283,017 Exercisable at September 30, 2021 4,143,324 $ 3.47 8.5 $ 15,852,955 Weighted Average Remaining Exercise Contractual Intrinsic Options Price Term (Yrs) Value Outstanding at July 1, 2020 4,092,593 $ 3.19 8.4 $ 5,553,916 Options Granted 108,324 4.50 9.9 - Options Exercised - - - - Options Forfeited / Cancelled (16,809 ) 4.33 9.4 (2,828 ) Outstanding at September 30, 2020 4,184,108 $ 3.22 8.4 $ 5,469,339 Exercisable at September 30, 2020 3,840,479 $ 3.14 8.4 $ 5,337,626 THE GLIMPSE GROUP, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) SEPTEMBER 30, 2021 AND 2020 The Company’s stock option-based expense for the three months ended September 30, 2021 and 2020 consisted of the following: SCHEDULE OF STOCK OPTION-BASED EXPENSE Three Months Ended Three Months Ended Stock option-based expense : Research and development expenses $ 347,597 $ 403,912 General and administrative expenses 66,643 98,163 Sales and marketing expenses 127,992 99,300 Cost of goods sold 22,764 45,687 Board option expense 88,619 42,751 Total $ 653,615 $ 689,813 During the year ended June 30, 2019, certain Company advisors received approximately $ 320,000 5.25 three-year term, for potential services to be performed over a three-year 320,000 29,000 58,000 29,000 At September 30, 2021, total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $ 1.06 1.85 1.19 0.83 The intrinsic value of stock options at September 30, 2021 was computed using a fair market value of the common stock of $ 7.29 4.50 |